The page is the record's research on the issuer — no analyst, no rating, no view.

VIROMED MEDICAL NA O.N. (VME) — research page

DE · de-cm-kg/XETRA/VME · as of 2026-11-06

Identity and listing

VIROMED MEDICAL NA O.N. is listed on Xetra under the ticker VME, with ISIN DE000A40ZVN7 and LEI 894500XR05MYCVCCR171. Its security type is Corporate and its segment is DEUTSCHLAND. Its sector is not on the record, as the Xetra instruments file carries index membership and not a sector classification. Its jurisdiction is Germany (Handelsregister HRB). Its status is listed, not halted.

fieldvaluesource · read date
nameVIROMED MEDICAL NA O.N.source · 2026-11-06
exchangeXetrasource · 2026-11-06
tickerVMEsource · 2026-11-06
ISINDE000A40ZVN7source · 2026-11-06
LEI894500XR05MYCVCCR171source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentDEUTSCHLANDsource · 2026-11-06
sectornot on the record
jurisdictionGermany (Handelsregister HRB)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 31 filings in the twelve months to 2026-11-06, across 16 filing days. By type, the record holds 2 ad hoc, 13 corporate news, 7 directors' dealings and 9 newswire release filings. The median gap between filing days is 8 days. The latest filing is dated 2026-11-06 and is a directors' dealings filing, 0 days before the record date. Xetra's median cadence gap is 22.8 days across 419 issuers, its median filings are 6, and its median latency is 5.5 days. The sector median is not on the record for this market.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer3180
exchange median: Xetra (419 issuers)622.85.5
datetypecategoryfiling
2026-11-06directors_dealingsdirectors-dealingsViromed Medical AG: Heike Perbandt, sell
2026-11-05directors_dealingsdirectors-dealingsViromed Medical AG: Heike Perbandt, sell
2026-11-05directors_dealingsdirectors-dealingsViromed Medical AG: Heike Perbandt, Verkauf
2026-11-05corporate_newscorporateViromed Medical AG erhält Zulassung für ViroCAP® med in der Türkei und gibt weitere operative Fortschritte bekannt | Corporate - EQS News
2026-11-04corporate_newscorporateViromed Medical AG Receives Approval for ViroCAP® med in Turkey and Announces Further Operational Progress | Corporate - EQS News

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record. The record carries the annual report link only, as a source link and not a read. The auditor's location is not on the record. Auditor changes are not on the record, as no lifecycle type map exists yet for this register.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as no lifecycle type map exists yet for this register. The halt flag is listed, not halted.

Orderability

The outcome for Professionelle Kunden is ACM-200, determinable. The outcome for Privatkunden is ACM-200, determinable. The outcome for Geeignete Gegenparteien is ACM-200, determinable. The rule version is acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Geeignete GegenparteienACM-200
PrivatkundenACM-200
Professionelle KundenACM-200

rule acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The record finds no research houses named on the issuer's own investor-relations page, count 0.

Open research

The record finds no openly published research notes for this issuer.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage is not sealed for this market. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.xetra.com/xetra-en/instruments/shares/list-of-tradable-shares (identity.exchange)
10.2
https://api.gleif.org/api/v1/lei-records/894500XR05MYCVCCR171 (identity.jurisdiction)
10.3
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.4
https://mcp.de-cm-kg.ai/events/XETRA/VME (the disclosure lines)
10.5
https://www.cashmarket.deutsche-boerse.com/cash-en/Stay-Informed/current-regulatory-topics/mifid-ii-releases/4086638!suspension-list (the halt flag)
10.6
https://mcp.de-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.de-cm-kg.ai/record/XETRA/VME (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DE000A40ZVN7"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:76dc24ad969948e7.